Legal Representation
Attorney
Ajay A. Jagtiani
USPTO Deadlines
Next Deadline
2060 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-04)
Due Date
March 04, 2031
Grace Period Ends
September 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
14 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 4, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Mar 4, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jan 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 20, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 20, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 20, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 20, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Dec 20, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Dec 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 17, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jun 5, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 040
Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents.
First Use Anywhere:
May 9, 2024
First Use in Commerce:
May 9, 2024
Class 042
Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays.
First Use Anywhere:
May 9, 2024
First Use in Commerce:
May 9, 2024
Additional Information
Design Mark
The mark consists of the words ANDELYN BIOSCIENCES with four hexagons to the right of the word BIOSCIENCES.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO